IQVIA Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 27, 2022 at 07:05 am EDT
Share
IQVIA Holdings Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 3,568 million compared to USD 3,409 million a year ago. Net income was USD 325 million compared to USD 212 million a year ago. Basic earnings per share from continuing operations was USD 1.71 compared to USD 1.11 a year ago. Diluted earnings per share from continuing operations was USD 1.68 compared to USD 1.09 a year ago.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;
- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;
- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.
Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
IQVIA HOLDINGS INC. 
